127 related articles for article (PubMed ID: 11489823)
1. Biological behavior of human breast cancer micrometastases.
Klauber-DeMore N; Van Zee KJ; Linkov I; Borgen PI; Gerald WL
Clin Cancer Res; 2001 Aug; 7(8):2434-9. PubMed ID: 11489823
[TBL] [Abstract][Full Text] [Related]
2. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.
Barnhill RL; Piepkorn MW; Cochran AJ; Flynn E; Karaoli T; Folkman J
Arch Dermatol; 1998 Aug; 134(8):991-4. PubMed ID: 9722729
[TBL] [Abstract][Full Text] [Related]
3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
4. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
[TBL] [Abstract][Full Text] [Related]
6. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
Andersson Y; Bergkvist L; Frisell J; de Boniface J
Breast Cancer Res Treat; 2018 Sep; 171(2):359-369. PubMed ID: 29846847
[TBL] [Abstract][Full Text] [Related]
7. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
8. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
[TBL] [Abstract][Full Text] [Related]
10. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.
Tvedskov TF; Bartels A; Jensen MB; Paaschburg B; Kroman N; Balslev E; Brünner N
APMIS; 2011 Dec; 119(12):844-52. PubMed ID: 22085360
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of vascular density and cell proliferation in breast cancer patients.
Tynninen O; von Boguslawski K; Aronen HJ; Paavonen T
Pathol Res Pract; 1999; 195(1):31-7. PubMed ID: 10048092
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive carcinoma of the breast: angiogenesis and cell proliferation.
Cao Y; Paner GP; Kahn LB; Rajan PB
Arch Pathol Lab Med; 2004 Aug; 128(8):893-6. PubMed ID: 15270612
[TBL] [Abstract][Full Text] [Related]
13. [Angiogenesis and micrometastases of regional lymph node in ovarian cancer].
Liang YJ; Wu YZ; Gu MJ
Ai Zheng; 2003 Feb; 22(2):185-8. PubMed ID: 12600297
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of angiogenesis of axillary lymph node metastasis in human breast carcinoma].
Wu L; Zhang W; Liu H
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):433-5. PubMed ID: 11776619
[TBL] [Abstract][Full Text] [Related]
15. Redox status in the sentinel lymph node of women with breast cancer.
Ramírez-Expósito MJ; Urbano-Polo N; Dueñas B; Navarro-Cecilia J; Ramírez-Tortosa C; Martín-Salvago MD; Martínez-Martos JM
Ups J Med Sci; 2017 Nov; 122(4):207-216. PubMed ID: 29264992
[TBL] [Abstract][Full Text] [Related]
16. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
Vartanian RK; Weidner N
Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
[TBL] [Abstract][Full Text] [Related]
17. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
[TBL] [Abstract][Full Text] [Related]
18. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
19. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer.
Menes TS; Tartter PI; Mizrachi H; Smith SR; Estabrook A
Ann Surg Oncol; 2003 Dec; 10(10):1166-70. PubMed ID: 14654472
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
